Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases

Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases

US Patent 9493431 · Granted Nov 15, 2016

Estimated economic value: $108,711,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Macrocyclic MCL-1 inhibitors and methods of use2020
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune d2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune d2018
Methods of treatment using selective Bcl-2 inhibitors2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2017